ULTRAGENYX PHARMACEUTICAL INC. (RARE) Operating margin 2016–2025
ULTRAGENYX PHARMACEUTICAL INC. (RARE) operating margin by fiscal year — reported operating income divided by reported revenue.
-79.5%FY2025 · since FY2016: -186471.4% → -79.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -79.5% | +16.2 pp |
| FY2024 | -95.7% | +35.4 pp |
| FY2023 | -131.1% | +47.5 pp |
| FY2022 | -178.6% | -70.0 pp |
| FY2021 | -108.6% | +13.2 pp |
| FY2020 | -121.8% | +287.2 pp |
| FY2019 | -409.0% | +312.2 pp |
| FY2018 | -721.2% | +11872.3 pp |
| FY2017 | -12593.5% | +173877.9 pp |
| FY2016 | -186471.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice